Clinical trials
Completed Cutaneous Squamous Cell Carcinoma trials in the Netherlands
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
6 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2019 | 1 |
| 2020 | 1 |
| 2022 | 1 |
| 2023 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 6 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Maastricht University Medical Center | 3 |
| Merck Sharp & Dohme LLC | 1 |
| Regeneron Pharmaceuticals | 1 |
| The Netherlands Cancer Institute | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cutaneous Squamous Cell Carcinoma | 6 |
| Basal Cell Carcinoma | 1 |
| Bowen's Disease | 1 |
| Carcinoma, Squamous Cell | 1 |
| Disease | 1 |
| Endometrial Neoplasms | 1 |
| Fibrosis | 1 |
| Keratosis, Actinic | 1 |
| Neoplasm Metastasis | 1 |
| Recurrence | 1 |
Trials
Showing 1 to 6 of 6. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.